Lessons from ECLIPSE: A review of COPD biomarkers

Rosa Faner, Ruth Tal-Singer, John H. Riley, Bartolomé Celli, Jørgen Vestbo, William MacNee, Per Bakke, Peter M.A. Calverley, Harvey Coxson, Courtney Crim, Lisa D. Edwards, Nick Locantore, David A. Lomas, Bruce E. Miller, Stephen I. Rennard, Emiel F.M. Wouters, Julie C. Yates, Edwin K. Silverman, Alvar Agusti

Research output: Contribution to journalReview articlepeer-review

91 Scopus citations

Abstract

The Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) study was a large 3-year observational controlled multicentre international study aimed at defining clinically relevant subtypes of chronic obstructive pulmonary disease (COPD) and identifying novel biomarkers and genetic factors. So far, the ECLIPSE study has produced more than 50 original publications and 75 communications to international meetings, many of which have significantly influenced our understanding of COPD. However, because there is not one paper reporting the biomarker results of the ECLIPSE study that may serve as a reference for practising clinicians, researchers and healthcare providers from academia, industry and government agencies interested in COPD, we decided to write a review summarising the main biomarker findings in ECLIPSE.

Original languageEnglish (US)
Pages (from-to)666-672
Number of pages7
JournalThorax
Volume69
Issue number7
DOIs
StatePublished - Jul 2014

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Lessons from ECLIPSE: A review of COPD biomarkers'. Together they form a unique fingerprint.

Cite this